Journals / European Archives of Medical Research / 2020 / Cilt: 36 - Sayı: 2

Retrospective Analysis of Tumor Location with Residue Rates in High-grade Glial Tumors

Pages
92–97
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

New prognostic parameters are needed based on new surgical approaches and imaging techniques.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Glioblastoma is the most commonly seen and quite an aggressive type of primary brain tumor.
📊
Key Findings & Data:The aim of this study was to present the retrospective data about glioblastoma patients in which location ofglioblastoma and calculation of residual tumor tissue was performed at our clinic.Methods: Tumor location, age and sex distributions, and residue presence in control magnetic resonance imaging (MRI) of 99 patients treatedat our clinic within the last two years with a high-grade glial tumor were examined retrospectively.
💡
Conclusion & Impact:New prognostic parameters are needed based on new surgical approaches and imaging techniques.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Glioblastoma is the most commonly seen and quite an aggressive type of primary brain tumor. Location of the tumor, age, and sexare important prognostic factors. The aim of this study was to present the retrospective data about glioblastoma patients in which location ofglioblastoma and calculation of residual tumor tissue was performed at our clinic.Methods: Tumor location, age and sex distributions, and residue presence in control magnetic resonance imaging (MRI) of 99 patients treatedat our clinic within the last two years with a high-grade glial tumor were examined retrospectively. Variables included in the analysis weredemographic data and the presence of residue on the control MRI within 24 hours. Chi-square test was used for comparisons. The data wereanalyzed by SPSS version 24.0 package program.Results: Of a total of 99 glioblastomas, the male/female ratio was 2:1, the average age of the patients was 54±37 (minimum: 18,maximum: 88; standard deviation: 15.08). In MRI, tumor was located at the frontal and temporal lobes with maximal percentile. In 55 ofthe cases, total resection was seen. In 38 of the cases, residue under 10% was seen, and in 6 of the cases, residual mass over 10% was seen.Relationship of tumor location with residual mass was not statistically significant (p=0.562).Conclusion: The aim of neurosurgery in glioblastomas is surgical excision to remove as much tumor as possible with minimal neurologicaldeficit. Preoperative characterization of the tumor through current imaging methods makes a significant contribution to mortality andmorbidity. New prognostic parameters are needed based on new surgical approaches and imaging techniques.

🔖

Cite This Article

DÜNDAR, T. T., PAPAKER, M. G., ÖZEK, E., SEYİTHANOĞLU, M. H., ABDALLAH, A., KİTİS, S. (2022). Retrospective Analysis of Tumor Location with Residue Rates in High-grade Glial Tumors. European Archives of Medical Research, Cilt: 36 - Sayı: 2, 92–97. https://ajindex.com/articles/510363

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Glaser T, Han I, Wu L, Zeng X. Targeted Nanotechnology in Glioblastoma Multiforme. Front Pharmacol 2017;8:166
  2. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012;14(Suppl 5):1-49
  3. Fyllingen EH, Hansen TI, Jakola AS, Håberg AK, Salvesen Ø, Solheim O. Does Risk of Brain Cancer Increase with Intracranial Volume? A Population-Based Case-Control Study. Neuro Oncol 2018;20:1225- 30 4. Petr J, Platzek I, Hofheinz F, Mutsaerts HJMM, Asllani I, van Osch MJP, et al. Photon vs. proton radiochemotherapy: Effects on brain tissue volume and perfusion. Radiother Oncol 2018;128:121-7
  4. Raysi Dehcordi S, De Paulis D, Marzi S, Ricci A, Cimini A, Cifone MG, et al. Survival prognostic factors in patients with glioblastoma: our experience. J Neurosurg Sci 2012;56:239-45
  5. Alvarez de Eulate-Beramendi S, Alvarez-Vega MA, Balbin M, SanchezPitiot A, VallinaAlvarez A, Martino-Gonzalez J. Prognostic factors and survival study in high-grade glioma in the elderly. Br J Neurosurg 2016;30:330-6
  6. Rozumenko A, Kliuchka V, Rozumenko V, Semenova V, Kolesnyk S, Fedorenko Z. Image-guided resection of glioblastoma in eloquent brain areas facilitated by laser surface thermal therapy: clinical outcomes and long-term results. Neurosurg Rev 2018;41:1045-52
  7. Mu L, Wang Y, Wang Y, Zhang H, Shang D, Tan F, et al. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression. World Neurosurg 2017;97:279- 83
  8. Pastrana E, Silva-Vargas V, Doetsch F. “Eyes wide open: a critical review of sphere-formation as an assay for stem cells.” Cell Stem Cell 2011;8:486-98
  9. Alifieris C, Trafalis DT. Glioblastoma multiforme: pathogenesis and treatment. Pharmacol Ther 2015;152:63-82
  10. Motiei-Langroudi R, Sadeghian H, M Mohammadi A. Subtotal Resection of a Thalamic Glioblastoma Multiforme through Transsylvian Approach. Cureus 2017;9:1662
  11. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006;2:494-503
  12. Prados MD, Wara WM, Edwards MS, Larson DA, Lamborn K, Levin VA. The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys 1995;32:85-91
  13. Sarıca FB, Yademir F, Cekinmez M, Kardeş Ö,Tufan K, Topkan E, ve ark. “Yeni Tanı Almış Glioblastoma Hastala